Cargando…

Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage

Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vecto...

Descripción completa

Detalles Bibliográficos
Autores principales: Grandchamp, Nicolas, Altémir, Dorothée, Philippe, Stéphanie, Ursulet, Suzanna, Pilet, Héloïse, Serre, Marie-Claude, Lenain, Aude, Serguera, Che, Mallet, Jacques, Sarkis, Chamsy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067480/
https://www.ncbi.nlm.nih.gov/pubmed/24956106
http://dx.doi.org/10.1371/journal.pone.0099649
_version_ 1782322299510194176
author Grandchamp, Nicolas
Altémir, Dorothée
Philippe, Stéphanie
Ursulet, Suzanna
Pilet, Héloïse
Serre, Marie-Claude
Lenain, Aude
Serguera, Che
Mallet, Jacques
Sarkis, Chamsy
author_facet Grandchamp, Nicolas
Altémir, Dorothée
Philippe, Stéphanie
Ursulet, Suzanna
Pilet, Héloïse
Serre, Marie-Claude
Lenain, Aude
Serguera, Che
Mallet, Jacques
Sarkis, Chamsy
author_sort Grandchamp, Nicolas
collection PubMed
description Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable.
format Online
Article
Text
id pubmed-4067480
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-40674802014-06-25 Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage Grandchamp, Nicolas Altémir, Dorothée Philippe, Stéphanie Ursulet, Suzanna Pilet, Héloïse Serre, Marie-Claude Lenain, Aude Serguera, Che Mallet, Jacques Sarkis, Chamsy PLoS One Research Article Gene transfer allows transient or permanent genetic modifications of cells for experimental or therapeutic purposes. Gene delivery by HIV-derived lentiviral vector (LV) is highly effective but the risk of insertional mutagenesis is important and the random/uncontrollable integration of the DNA vector can deregulate the cell transcriptional activity. Non Integrative Lentiviral Vectors (NILVs) solve this issue in non-dividing cells, but they do not allow long term expression in dividing cells. In this context, obtaining stable expression while avoiding the problems inherent to unpredictable DNA vector integration requires the ability to control the integration site. One possibility is to use the integrase of phage phiC31 (phiC31-int) which catalyzes efficient site-specific recombination between the attP site in the phage genome and the chromosomal attB site of its Streptomyces host. Previous studies showed that phiC31-int is active in many eukaryotic cells, such as murine or human cells, and directs the integration of a DNA substrate into pseudo attP sites (pattP) which are homologous to the native attP site. In this study, we combined the efficiency of NILV for gene delivery and the specificity of phiC31-int for DNA substrate integration to engineer a hybrid tool for gene transfer with the aim of allowing long term expression in dividing and non-dividing cells preventing genotoxicity. We demonstrated the feasibility to target NILV integration in human and murine pattP sites with a dual NILV vectors system: one which delivers phiC31-int, the other which constitute the substrate containing an attB site in its DNA sequence. These promising results are however alleviated by the occurrence of significant DNA damages. Further improvements are thus required to prevent chromosomal rearrangements for a therapeutic use of the system. However, its use as a tool for experimental applications such as transgenesis is already applicable. Public Library of Science 2014-06-23 /pmc/articles/PMC4067480/ /pubmed/24956106 http://dx.doi.org/10.1371/journal.pone.0099649 Text en © 2014 Grandchamp et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.
spellingShingle Research Article
Grandchamp, Nicolas
Altémir, Dorothée
Philippe, Stéphanie
Ursulet, Suzanna
Pilet, Héloïse
Serre, Marie-Claude
Lenain, Aude
Serguera, Che
Mallet, Jacques
Sarkis, Chamsy
Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
title Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
title_full Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
title_fullStr Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
title_full_unstemmed Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
title_short Hybrid Lentivirus-phiC31-int-NLS Vector Allows Site-Specific Recombination in Murine and Human Cells but Induces DNA Damage
title_sort hybrid lentivirus-phic31-int-nls vector allows site-specific recombination in murine and human cells but induces dna damage
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4067480/
https://www.ncbi.nlm.nih.gov/pubmed/24956106
http://dx.doi.org/10.1371/journal.pone.0099649
work_keys_str_mv AT grandchampnicolas hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT altemirdorothee hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT philippestephanie hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT ursuletsuzanna hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT piletheloise hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT serremarieclaude hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT lenainaude hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT serguerache hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT malletjacques hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage
AT sarkischamsy hybridlentivirusphic31intnlsvectorallowssitespecificrecombinationinmurineandhumancellsbutinducesdnadamage